The failure of ANTH's drug in ACS isn't a good sign for darapladib probably, although it targets a different class of phospholipase A2 enzyme but same superfamily of pro-inflammatory enzymes associated with atherosclerosis. Do you know if this plac test Clevelad lab offers is DDXS'?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.